EU-RESPONSE – European adaptive platform trial on COVID-19

Through ECRIN, Ireland will participate in EU-RESPONSE, a 5-year, €15.7M multinational project, funded by the European Union Horizon 2020 research and innovation program. The project will design and implement a new European adaptive platform clinical trial for COVID-19 treatments.

For further information, please see the ECRIN website

or for Ireland specific enquiries contact HRB CRCI